...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Merck's PIII Prostate trial, not the one with ZEN-3694, is halted for not showing improvement vs control

We need the Bear to break such analysis out so that we might have a chance to understand it!!,,Jmo.

Share
New Message
Please login to post a reply